(Q44315445)

1 December 2017

0 references

Clinical applications of DNA methylation biomarkers in colorectal cancer (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Christopher P E Lange

series ordinal

1

1 reference

1 December 2017

Peter W Laird

series ordinal

2

1 reference

1 December 2017

publication date

1 April 2013

1 reference

1 December 2017

1 reference

1 December 2017

volume

5

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

105-108

1 reference

1 December 2017

cites work

Global cancer statistics

1 reference

Promoter CpG island methylation markers in colorectal cancer: the road ahead

21 January 2018

1 reference

Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR

21 January 2018

1 reference

Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer

21 January 2018

1 reference

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

21 January 2018

1 reference

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.

21 January 2018

1 reference

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas

21 January 2018

1 reference

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

21 January 2018

1 reference

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.

21 January 2018

1 reference

The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia

21 January 2018

1 reference

Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer

21 January 2018

1 reference

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

21 January 2018

1 reference

TFAP2E-DKK4 and chemoresistance in colorectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.13.4

1 reference

1 December 2017

1 reference